The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Mechanisms of Disease
PreviousPrevious
Volume 338:1813-1821 June 18, 1998 Number 25
NextNext

The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
Mohamed H. Sayegh, M.D., and Laurence A. Turka, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Organ transplantation is now common. For patients with end-stage cardiac, hepatic, or pulmonary failure, it can be lifesaving.1 For patients with diabetes mellitus, pancreatic transplantation offers the chance of a cure and the arrest or reversal of diabetic complications such as neuropathy and retinopathy. In 1996 more than 19,410 organ and tissue transplantations were performed in the United States, and 53,755 patients were on waiting lists for transplantation.

Over the past two decades, the development of new immunosuppressive drugs with improved efficacy and decreased toxicity has led to substantial improvement in the survival of patients and in short-term graft survival . . . [Full Text of this Article]

Role of T Cells in Transplant Rejection

Current Concepts in Immunosuppression

The Role of Costimulatory Signals in T-Cell Activation

T-Cell Costimulatory Blockade in Transplant Rejection

Acute Rejection

Chronic Rejection

Blockade of the CD40:CD40 Ligand Pathway

Preliminary Studies of Transplantation in Large Animals

Conclusions


Source Information

From the Laboratory of Immunogenetics and Transplantation, Renal Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston (M.H.S.); and the Department of Medicine, University of Pennsylvania, Philadelphia (L.A.T.).

Address reprint requests to Dr. Turka at the University of Pennsylvania, 901 Stellar Chance Laboratories, 422 Curie Blvd., Philadelphia, PA 19104-6100.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.